During our study of ferroptosis in pancreatic cancer, we found that cytoplasmic polyadenylation element binding protein 1 (CPEB1) plays a critical role in controlling susceptibility to ferroptosis and is closely associated with clinical therapeutic outcomes. This evidence concerns the gene CPEB1 and familial pancreatic carcinoma.